Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Matrix metalloproteinase-2 polymorphism is associated with prognosis in prostate cancer.

Urologic oncology - 1 Jan 2000

dos Reis Sabrina Thalita, Villanova Fabiola Elizabeth, Andrade Priscila Maria, Pontes José, de Sousa-Canavez Juliana Moreira, Sañudo Adriana, Antunes Alberto Azoubel, Dall'oglio Marcos Francisco, Srougi Miguel, Moreira Leite Katia Ramos

Abstract excerpt

OBJECTIVE: Prostate cancer (PCa) is the most frequent tumor in males in Brazil. Single nucleotide polymorphisms (SNP) have been demonstrated in the promoter region of matrix metalloproteinases (MMPs) genes and have been associated with development and progression of some cancers. In this study, our aim was to investigate a possible relation between polymorphism of the promoter region of the MMP2 gene and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Brazil

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Matrix Metalloproteinase 2

Share to Neoplasm Staging

Share to Prognosis

Share to Promoter Regions, Genetic

Share to Prostatic Neoplasms

Share to Reverse Transcriptase Polymerase Chain Reaction

Source

Identifiers

PMID: 19117773
DOI: 10.1016/j.urolonc.2008.10.012

Genes

MMP2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Matrix metalloproteinase-2 polymorphism is associated with prognosis in prostate cancer.PMID 19117773Read ↗

Genetic polymorphisms of matrix metalloproteinases: susceptibility and prognostic implications for prostate cancer.Semantic proximity Read ↗

Genetic Polymorphism of MMP2 Gene and Susceptibility to Prostate Cancer.Semantic proximity Read ↗

The association between MMP2 -1306 C > T (rs243865) polymorphism and risk of prostate cancer.Semantic proximity Read ↗

Association of Matrix Metalloproteinase-2 Genotypes With Prostate Cancer Risk.Semantic proximity Read ↗

Association between MMP2-1306 C/T polymorphism and prostate cancer susceptibility: a meta-analysis based on 3906 subjects.Semantic proximity Read ↗

Association of promoter polymorphisms in MMP2 and TIMP2 with prostate cancer susceptibility in North India.Semantic proximity Read ↗

Significance of MMP-9 expression and MMP-9 polymorphism in prostate cancer.Semantic proximity Read ↗

Current evidence on the relationships among five polymorphisms in the matrix metalloproteinases genes and prostate cancer risk.Semantic proximity Read ↗

Polymorphisms in COX-2 gene influence prostate cancer susceptibility in a northern Indian cohort.Semantic proximity Read ↗

Polymorphisms in MMP-2 and TIMP-2 in Turkish patients with prostate cancer.Semantic proximity Read ↗

Exploratory study of a KLK2 polymorphism as a prognostic marker in prostate cancer.Semantic proximity Read ↗

Clinical significance of a single nucleotide polymorphism and allelic imbalance of matrix metalloproteinase-1 promoter region in prostate cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.